TrialJournal of clinical microbiology2000

Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance.

M Mouroux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.